Oxford Drug Design
UK - OxfordBiotechnology
Focus: Oxford Drug Design is a UK-based biotechnology company specializing in antibiotics and infectious disease treatments. The company operates a portfolio of generic and branded anti-infective medications.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Oxford Drug Design
AI assessmentNot HiringNo open roles listed right now. Follow Oxford Drug Design to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Oxford Drug Design's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
Post-LOE
CNS stimulant approved via ANDA; post-LOE status indicates mature generic market with commoditized pricing.
Help build intelligence for Oxford Drug Design
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.